Tag
Regulatory Action
10 articles
Mangalam Global Enterprise Directors, Officers Settle SEBI Case
SEBI settles with eight individuals, including independent directors and compliance officers of Mangalam Global Enterprise, for alleged violations of LODR and PFUTP regulations.
The settlement involve
SEBI Bars AFCO Capital from New Merchant Banking Business for One Month
SEBI has prohibited AFCO Capital India from taking new merchant banking clients for one month for multiple regulatory violations.
The order cites failures in due diligence, outsourcing of core functio
SEBI Penalizes Rajeev Chandak HUF for Illiquid Stock Options Fraud
SEBI imposes a ₹5 lakh penalty on Rajeev Chandak HUF for executing non-genuine reversal trades in illiquid stock options on BSE.
The Adjudicating Officer found the entity created artificial volume via
Kaynes Tech MD Settles SEBI Insider Trading Case
SEBI settles case against Kaynes Tech MD for Rs 23.42 lakh for failing to maintain a structured digital database for UPSI.
The company failed to properly log UPSI related to strong financial results,
SEBI Penalizes Ashlar Securities for TradeTron Association
SEBI imposes a penalty of ₹1 lakh on Ashlar Securities for violating a 2022 circular by remaining associated with the TradeTron algo platform that displayed assured returns.
The Adjudicating Officer f
SEBI Penalizes Shri Parasram Holdings for Algo Platform Violations
SEBI imposes a penalty of ₹2 lakh on Shri Parasram Holdings for violating a 2022 circular by remaining associated with TradeTron, an algo platform offering assured returns.
The company's API integrati
SEBI imposes ₹3 lakh penalty on Samco Securities for algo platform violations
SEBI imposes a penalty of ₹3 lakh on Samco Securities for violating regulations by associating with algo platforms making assured return claims.
The order cites violations of SEBI's September 2022 cir
Lal Kamleshbhai N HUF Penalized ₹5 Lakh for Illiquid Options Manipulation
SEBI adjudication order imposes a ₹5 lakh penalty on Lal Kamleshbhai N HUF for executing non-genuine reversal trades in illiquid stock options on the BSE.
The entity executed two reversal trades in a
SEBI Censures Streetgains Research for Assured Returns, Mis-selling
SEBI's final order censures Streetgains Research Services for assuring returns, mis-selling, and advertising past performance on social media.
The order follows an inspection that found multiple viola
SEBI Confirms Interim Order Halting Par Drugs Slump Sale
SEBI confirms interim order halting Par Drugs' slump sale to a promoter entity, citing undervaluation and disclosure lapses.
Independent valuation ordered after SEBI found the proposed sale undervalue